Fairfield, Bush & Co. Accelerate Diagnostics, Inc Transaction History

Fairfield, Bush & Co.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	BUY	$1.4 - $5.15 $875 - $3,218	625 New	625 $1,000
Q4 2020 Feb 12, 2021	SELL	$7.04 - $11.7 $128,085 - $212,869	-18,194 Closed	0 $0
Q3 2020 Nov 18, 2020	SELL	$9.98 - $18.04 $34,890 - $63,067	-3,496 Reduced 16.12%	18,194 $193,000
Q2 2020 Aug 13, 2020	BUY	$7.49 - $15.16 $187 - $379	25 Added 0.12%	21,690 $329,000
Q1 2020 May 13, 2020	BUY	$4.62 - $18.74 $16,170 - $65,590	3,500 Added 19.27%	21,665 $180,000
Q4 2019 Feb 12, 2020	BUY	$14.6 - $18.13 $108,405 - $134,615	7,425 Added 69.13%	18,165 $306,000
Q3 2019 Nov 13, 2019	BUY	$16.62 - $23.92 $178,498 - $256,900	10,740 New	10,740 $199,000
Q4 2018 Feb 11, 2019	SELL	$10.42 - $21.94 $107,221 - $225,762	-10,290 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$22.55 - $29.9 $12,402 - $16,445	-550 Reduced 5.07%	10,290 $235,000
Q2 2017 Aug 15, 2017	BUY	N/A	10,840	10,840 $296,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $119M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

Stay updated on Fairfield, Bush & Co. with notifications on news.